Pharmacogenomics describes the link between the genetic code and variations in drug
response or adverse effects. It is rapidly gaining in both interest and accessibility. The …

Pharmacogenomics has been slow to be implemented in clinical practice, particularly for
commonly administered, chronic medications. In many ways, this is not surprising …

Pharmacogenomics and its predecessor pharmacogenetics study the contribution of genetic
factors to the interindividual variability in drug efficacy and safety. One of the major goals of …

Pharmacogenomics is a growing field of research that links genetic variation with drug
effects to determine impact on pharmacology and clinical application. Relationships …

Pharmacogenomics is focused on the identification of genetic variant markers that influence
an individual's drug response profile through alterations in pharmacokinetics or …

Background: Patients respond to medications differently because of variations in the genes
that determine medication exposure and medication response. Objective: The aim of this …

Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic
variation on drug response in patients by correlating gene expression or single-nucleotide …

Genetic factors have long been recognized as important determinants of interindividual
variability in drug efficacy and toxicity. However, despite the increasing number of …

There is considerable interindividual variability in the effectiveness and safety of medicines.
Although the reasons for this are multifactorial, it is well recognised that genetic changes …

Pharmacogenetics and pharmacogenomics strive to explain the interindividual variability in
response to drugs due to genetic variation. For certain drugs, genetic tests can reduce …